Click here for Prescribing Information for Cordran Cream and Ointment
Click here for Prescribing Information for Cordran Lotion
Indication for both Cordran Lotion and Cordran Cream 0.05%
Cordran Lotion and Cordran Cream 0.05% are both indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Important Safety Information Regarding Both Cordran Lotion and Cream 0.05%
- Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria.
- Increased absorption may occur with the use of more potent steroids, use over large surface areas or with occlusive dressings, prolonged use, or use in pediatric patients.
- Patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression using urine free cortisol and ACTH stimulation tests.
- Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than do adults because of a larger skin surface area to body weight ratio.
- Local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings.
- The most common adverse events with both Cordran Lotion and Cordran Cream 0.05% were burning, itching, irritation, and dryness.
- The following adverse reactions have been identified during post-approval use of Cordran Lotion: hypersensitivity, contact dermatitis, skin discoloration, skin striae and skin atrophy.